Today, on World Health Day, we focus on global health challenges, taking the opportunity to raise awareness about kidney health. Join Urmila Anandh, Elliot Tannor, and María José Soler in the X Space “Advancing global kidney health: Building consensus for the WHO resolution” at 3 p.m. CEST today (April 7). Access the ISN X Space...
ISN President Marcello Tonelli launched the ISN Manifesto at WCN'25. This call to action outlines key advocacy and policy recommendations directed at UN Member States and national, regional and local policymakers. Read the manifesto here Why global action is needed Kidney disease affects over 850 million people globally, with a significant impact on mortality rates. It is...
The ISN is proud to support the proposed World Health Organization (WHO) resolution "Reducing the Burden of Non-Communicable Diseases (NCDs) through the Promotion of Kidney Health and Strengthening Prevention and Control of Kidney Disease." A global call to action At the 156th WHO Executive Board Meeting (February 3–11, 2025), the ISN will formally present its statement...
The “ISN Global Kidney Trials Insights: A Guide for Everyone,” inspired by the ISN-ACT Global Trials Focus summaries, translates complex trial findings into accessible information. This initiative empowers people living with kidney disease and their caregivers to better understand advancements in kidney care. Access all the simplified summaries here. The latest case study features the SMART...
In September, the ISN had a powerful presence at UNGA79, successfully raising awareness of the human and economic burden of kidney disease while garnering support from Member States to promote kidney health within the broader noncommunicable disease (NCD) agenda. The ISN’s aims at the event were threefold: Raise awareness about the urgent need to prioritize kidney...
The ISN has launched an online petition calling on all to join forces toward elevating kidney disease as a global health priority. We want 1 million signatures by the end of the year – and we need your support! Read more about the petition and add your signature Kidney disease is one of the leading causes...
The ISN is excited to announce its participation at the United Nations General Assembly (UNGA) in September. On September 25, the ISN will host a series of dedicated activities in New York focused on raising awareness of and driving action on kidney disease: ISN exhibit booth: "Kidney Health Matters: Prioritizing the Silent Epidemic" The booth will highlight...
As a non-state actor in official relations with the WHO, the ISN attended the WHO's "Global high-level technical meeting on noncommunicable diseases in humanitarian settings: building resilient health systems, leaving no one behind" in Copenhagen, Denmark, at the end of February. Denmark, Kenya, and Jordan hosted 630 participants from 50 countries and 71 non-governmental organizations...
Ele Ferrannini, a professor of Internal Medicine at the University of Pisa and a senior research associate at the National Research Council Institute of Clinical Physiology, will present the plenary talk "Insights Into SGLT2 Inhibitors: A Story of Discovery" at WCN'24 in Hall A on Tuesday, April 16 at 11 a.m. Argentina time. Register for...
The International Diabetes Federation Virtual Congress 2023, 4-7 December, will feature four days of high-level sessions on: Managing and treating diabetes complications, The impact of natural and human-made disasters on people with diabetes The long-term effects of COVID-19 Attractive registration rates are available, with discounts for students and healthcare professionals in low- and middle-income countries. Learn more at www.idf2023.org.
Obiageli Nnodu, professor of Hematology and Blood Transfusion and director of the Centre of Excellence for Sickle Cell Disease Research and Training at the University of Abuja in Nigeria, will present the talk "Crispcas9 Therapy for Sickle Cell Diseases: How Do We Go From Discovery to Equitable Availability of Gene Therapy for All?" at...
The Global Coalition for Circulatory Health (GCCH), of which ISN is a member of its leadership group, has published a position paper, "The Road to Universal Health Coverage (UHC): Why Integration of Circulatory Health Interventions in Primary Care is Essential." Access the full position paper here. Below, we've summarized the crucial points from the paper: The financial...
Valerie Luyckx, ISN Advocacy Working Group chair, was invited to join a panel of experts at the World Heart Federation's Heart Café Session "Navigating the Complex Relationship Between Chronic Kidney Disease and Cardiovascular Complications," held as part of the European Society of Cardiology (ESC) Congress in Amsterdam, the Netherlands. Watch a recording of the event...
The ISN was represented at the SIDS Ministerial Conference by Dr. Lori Ann Fisher and Dr. Raquel Lowe Jones, nephrologists associated with the University of the West Indies in Jamaica, and ISN North America and Caribbean Regional Board members. The SIDS Ministerial Conference in Barbados from June 13 to 16 addressed the high burden of...
The ISN is pleased to announce that the joint IDF-ISN policy brief “Renewing the Fight: A Call to Action for Diabetes and Chronic Kidney Disease” will be launched at a webinar taking place on July 13, 2023, from 2-3.15 p.m. CEST. Register for the webinar here. Aimed at advocates, healthcare professionals, and policymakers involved with people...
Kidney diseases are intricately linked to increased morbidity with, and mortality from, other diseases and infections. An integrated approach to noncommunicable disease prevention and management that recognizes co-morbidities is critical to improving disease outcomes. Since 2021, the ISN has collaborated with the American Society of Preventative Cardiology (ASP), the Heart Failure Association of the European Society of Cardiology (HFA), Kidney...
The ISN, in partnership with the media platform Devex, held a side event of the 76th World Health Assembly (WHA76) in Geneva on May 24, 2023. The purpose of this gathering was to discuss the steps that are needed to make kidney health a priority in national and international policy. Speakers provided different perspectives on...
The ISN attended the 76th World Health Assembly (WHA) in Geneva from May 21 to 30, 2023, presenting five separate constituency statements and holding an inaugural stand-alone event in collaboration with Devex. Statements Three joint statements, co-signed with partners in the NCD Alliance and the World Heart Federation (WHF), focused on the following: Prioritizing noncommunicable diseases (NCDs),...
Members of the ELP cohorts attend a webinar to hear Dr. Slim Slama’s presentation On April 17, the ISN Emerging Leaders cohorts from 2021 and 2022 had the honor of hearing Dr. Slim Slama, Unit Head for Non-Communicable Disease (NCD) Management at the World Health Organization (WHO), present on the leadership skills required for NCD...
The ISN submitted three statements supporting global kidney health when it participated in the 152nd session of the World Health Organization’s Executive Board from January 30 to February 7, 2023. This annual meeting gathers WHO executive board members at the start of each year to agree on World Health Assembly agenda resolutions for consideration by...
